Replies to post #66801 on Anavex Life Sciences Corp (AVXL)

[JB3729]

Someone posted info on the next A2-73 trial at Caulfield Hospital. The patients for that trial are required to be taking Aricept. If Anavex continues to dose A2-73 and Aricept in their future Alzheimer's trial(s), then Anavex Plus is what will be considered for FDA approval.

The Anavex Plus patent is very important at this juncture.